摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Cu(CH3OC6H3(O)CHNCH2CH2NH2)(pyridine)](perchlorate) | 1037741-21-1

中文名称
——
中文别名
——
英文名称
[Cu(CH3OC6H3(O)CHNCH2CH2NH2)(pyridine)](perchlorate)
英文别名
——
[Cu(CH3OC6H3(O)CHNCH2CH2NH2)(pyridine)](perchlorate)化学式
CAS
1037741-21-1
化学式
C15H18CuN3O2*ClO4
mdl
——
分子量
435.323
InChiKey
NPUQXWMLOBLKLV-OKDQOLBWSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    2-吡咯甲醛[Cu(CH3OC6H3(O)CHNCH2CH2NH2)(pyridine)](perchlorate) 在 NaOH 作用下, 以 甲醇 为溶剂, 以55%的产率得到[Cu(CH3OC6H3(O)CHNCH2CH2NCHC4H3N)]
    参考文献:
    名称:
    Di- and Triheteronuclear Cu−Gd and Cu−Gd−Cu Complexes with Dissymmetric Double Bridge
    摘要:
    The study of the Cu-Gd interaction is simplified by the use of heteronuclear Cu-Gd complexes of low nuclearity, such as dinuclear Cu-Gd or trinuclear Cu-Gd-Cu complexes. In the large majority of cases published until now, this interaction presents the advantage of being ferromagnetic. Among the known examples, the complexes with the largest J values have been prepared with use of symmetric Schiff base compartmental ligands, so that the active cores of the molecules involve two phenoxo bridges between the copper and gadolinium ions. Keeping this remark in mind, we decided to synthesize simple complexes in which two different bridges link the copper and gadolinium ions. The structural determinations of a heterodinuclear Cu-Gd and a trinuclear Cu-Gd-Cu complex confirm the asymmetry of the central cores, involving phenoxo and hydroxo bridges. The magnetic studies evidence again the presence of ferromagnetic interactions. These results corroborate preponderance of the planarity of the Cu-O-2-Gd core over the dissymmetry of the bridges.
    DOI:
    10.1021/ic800599r
  • 作为产物:
    描述:
    copper(II) perchlorate hexahydrate 、 邻香草醛乙二胺吡啶 作用下, 以 甲醇 为溶剂, 生成 [Cu(CH3OC6H3(O)CHNCH2CH2NH2)(pyridine)](perchlorate)
    参考文献:
    名称:
    具有 NN'O 型不对称席夫碱的新型混合配体 Cu(II) 复合物的细微结构变化:针对 SARS-Cov-2 及其 Omicron 变体主要蛋白酶的分子对接
    摘要:
    多种新型混合配体席夫碱配合物通式为 [Cu(SBn)(py)]ClO4 (n = 1–5) 和 [Cu(SBn)(BTZ)]ClO4 (n = 1a–5a)合成并表征。在这些配合物中,NN'O型不对称席夫碱配体(SBn)由1,2-乙二胺与水杨醛(1, 1a)、3-甲氧基水杨醛(2, 2a)、3,5等摩尔缩合形成。 -二溴水杨醛(3, 3a)、3-甲氧基-5-溴水杨醛(4, 4a)和6-甲氧基水杨醛(5, 5a)。通过 FT-IR 和 UV-Vis 光谱以及元素分析对配合物进行了表征。配合物3、2a、3a、4a和5a的晶体结构也通过单晶X射线衍射(SCXRD)获得。对 SARS-Cov-2 Mpro (PDB ID: 6LU7) 和 SARS-CoV-2 Omicron Variant 蛋白酶 (PDB ID: 7TLL) 进行了分子对接研究。根据估计的自由结合能 (EFBE),复合物 (3a)
    DOI:
    10.1016/j.inoche.2023.111795
点击查看最新优质反应信息

文献信息

  • Anion directed templated synthesis of mono- and di-condensed Schiff base compounds of Cu(II)
    作者:Prasanta Bhowmik、Subrata Jana、Shouvik Chattopadhyay
    DOI:10.1016/j.poly.2012.05.035
    日期:2012.8
    A mono-condensed Schiff base ligand has been prepared as the Cu(II) compound, [Cu-2(L-1)(2)(N-3)(2)]center dot 2H(2)O (1) (HL1 = 1-(N-3-methoxysalicylaldimine)-2-aminoethane), by the reaction of 1,2-diaminoethane, Cu(II) perchlorate and 3-methoxysalicyaldehyde in a 1:1:1 ratio in methanol, followed by the reaction with a large excess of NaN3. In absence of NaN3, a di-condensed compartmental ligand has been trapped as its Cu(II) compound [Cu-2(L-2)(2)subset of(H3NC2H4NH3)][CuL2)(2)subset of(H3NC2H4NH3)](ClO4)(4) (2) (H2L2 = N,N'-ethylene-bis(3-methoxysalicylaldimine). Both compounds were characterized by elemental analyses, spectral and electrochemical studies and single crystal X-ray diffraction. In compound 2, Cu(II) has a square planar coordination geometry, while in 1, Cu(II) exhibits a distorted square pyramidal geometry (Addison parameter (tau) = 0.116). [CuL1(py)](ClO4) (3) is produced by following the preparation method of compound 1, but replacing NaN3 with pyridine. Formation of the compounds has been explained by an anion directed template effect. (c) 2012 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)